← SynDRA
CARMOXIROLE
SynDRA canonical compound SYN0003061 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DRD2 |
|---|
| Mechanism of action | Dopamine receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Dopamine receptor agonist
- DRD2 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- APEX1
- HDAC6
- HSD17B10
- KDM4E
- KMT2A
- POLK
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- CP2D6
- CP3A7
- DRD3
- KSYK
- SYK
Cross-references
Synonyms
- Carmoxirol
- Carmoxirole hydrochloride
- EMD-45609
- Carmoxirolum
- MRP4P457ZA
- DTXCID8023892
- CHEBI:64200
- RefChem:123749
- Carmoxirole [INN]
- Carmoxirol [INN-Spanish]
- Carmoxirolum [INN-Latin]
- CAS-98323-83-2
- NCGC00092328-01
- UNII-MRP4P457ZA
- CARMOXIROLE [MI]
- SCHEMBL146312
- orb1741291
- SCHEMBL31723392
- AFSOIHMEOKEZJF-UHFFFAOYSA-N
- Tox21_111193
- EX-A15097
- Tox21_111193_1
- NCGC00092328-02
- DA-00064
- CS-0025033
- NS00120056
- T68190
- BRD-K82484965-003-02-7
- BRD-K82484965-003-03-5
- BRD-K82484965-003-04-3
- 3-(4-(3,6-Dihydro-4-phenyl-1(2H)-pyridyl)butyl)indole-5-carboxylic acid
- CHEBI:64199
- DTXCID2022595
- HY-103410
- T10683
- RefChem:123750
- UNII-77K7K97CBS
- MS-27095
Look up CARMOXIROLE in the interactive SynDRA portal →